Absceso hepático y bacteriemia por Schaalia odontolytuca en un paciente inmunocomprometido
Keywords:
absceso hepático, actinomicosis, Schaalia odontolyticaAbstract
Presented here is a case of hepatic abscess with bacteremia due to Schaalia odontolytica, Gram-positive bacilli of Actinomycesgenus, which is a member of the human oropharynx tract and under certain circumstances, can act like opportunistic pathogen. This specie is an infrequent cause of abdominal actinomycosis. Because the insidious course and the nonspecific nature of the symptoms, its differential diagnosis is crucial for the accurate treatment. On this particular case, is highlighted the previous abdominal surgery and immune suppression stand out as factors for the suspicion of opportunistic pathogens and for the prolonged incubation of cultures, considering the need to use molecular techniques as diagnostic tools.
References
Valour F., Sénéchal A., Dupieux C., Karsenty J., Lustig S., Breton P. y col.. Actinomycosis: etiology, clinical features, diagnosis, treatment, and management. Infect Drug Resist. (2014) 7: 183-197.
Smego R.A. Jr., Foglia G. Actinomycosis. Clin Infect Dis. (1998) 26: 1255- 1261.
Garner J.P., Macdonald M., Kumar P.K. Abdominal Actinomycosis. Int J Surg. (2007) 5: 441-448.
Cone L.A., Leung M.M., Hirschberg J. Actinomyces odontolyticus bacteremia. Emerg Infect Dis. (2003) 9: 1629-1632.
Galata C.L., Vogelmann R., Gaiser T., Post S., Horisberger K. Abdominopelvic Actinomycosis in three different locations with invasion of the abdominal wall and ureteric obstruction: An uncommon presentation. Int J Surg Case Rep. (2015) 12: 48-51.
Petrache D., Popescu G.A. Successful switch to oral therapy with doxycycline in the case of an actinomycotic hepatic abscess. J Infect Dev Ctries. (2013) 7: 421-423.
Wong J.J., Kinney T.B., Miller F.J., Rivera-Sanfeliz G. Hepatic actinomycotic abscesses: diagnosis and management. AJR Am J Roentgenol. (2006) 186: 174-176.
Smith A.J., Hall V., Thakker B., Gemmel C.G. Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents. J Antimicrob Chemother. (2005) 56: 407-409. Acevedo F., Baudrand R., Letelier L.M., Gaete P. Actinomycosis: a great pretender. Case reports of unusual presentations and a review of the literature. Int J Infect Dis. (2008) 12: 358-362.
Filipa A., Santos V., Massinha P. Pereira J.R., Quintanilha R., Figueiredo A. Hepatic Actinomycosis. GE Port J Gastroenterol. (2015) 22: 19-23.
Wagenlehner F.M.E., Morhen B., Naber K.G., Männl H.F.K. Abdominal actinomycosis. Clin Microb Infect. (2003) 9: 881-885.
Grossen A., Magguilli M., Thai T.C., Salem G. Hepatic actinomycosis in a patient with retained common bile duct stent. ACG Case Rep J. (2019) 6: 1-3.
Lall T., Shehab T.M., Valenstein P. Isolated hepatic actinomycosis: a case report. J Med Case Reports. (2010) 4: 1-4.
Gajdács M., Urbán E., Terhes G. Microbiological and clinical aspects of cervicofacial Actinomyces infections: an overview. Dent J. (2019) 7: 1-16
Downloads
Published
Issue
Section
License
Licencia Creative Commons BY NC
Usted es libre de:
- Compartir — copiar y redistribuir el material en cualquier medio o formato
- Adaptar — remezclar, transformar y construir a partir del material
- La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia
Bajo los siguientes términos:
-
Atribución — Usted debe dar crédito de manera adecuada, brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
-
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
